Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Revenue (2023 - 2024)

Spruce Biosciences (SPRB) has disclosed Revenue for 2 consecutive years, with $697000.0 as the latest value for Q4 2024.

  • Quarterly Revenue fell 75.97% to $697000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $697000.0 through Sep 2025, down 90.19% year-over-year, with the annual reading at $4.9 million for FY2024, 51.38% down from the prior year.
  • Revenue for Q4 2024 was $697000.0 at Spruce Biosciences, up from $602000.0 in the prior quarter.
  • The five-year high for Revenue was $3.1 million in Q3 2023, with the low at $602000.0 in Q3 2024.